Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice.

Cloonan SM, Glass K, Laucho-Contreras ME, Bhashyam AR, Cervo M, Pabón MA, Konrad C, Polverino F, Siempos II, Perez E, Mizumura K, Ghosh MC, Parameswaran H, Williams NC, Rooney KT, Chen ZH, Goldklang MP, Yuan GC, Moore SC, Demeo DL, Rouault TA, D'Armiento JM, Schon EA, Manfredi G, Quackenbush J, Mahmood A, Silverman EK, Owen CA, Choi AM.

Nat Med. 2016 Feb;22(2):163-74. doi: 10.1038/nm.4021. Epub 2016 Jan 11.

2.

Revisiting Metal Toxicity in Neurodegenerative Diseases and Stroke: Therapeutic Potential.

Mitra J, Vasquez V, Hegde PM, Boldogh I, Mitra S, Kent TA, Rao KS, Hegde ML.

Neurol Res Ther. 2014;1(2). pii: 107.

3.

Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Kolnagou A, Kontoghiorghe CN, Kontoghiorghes GJ.

World J Methodol. 2014 Dec 26;4(4):197-218. doi: 10.5662/wjm.v4.i4.197. eCollection 2014 Dec 26. Review.

4.

Cerebellar pathology in Friedreich's ataxia: atrophied dentate nuclei with normal iron content.

Solbach K, Kraff O, Minnerop M, Beck A, Schöls L, Gizewski ER, Ladd ME, Timmann D.

Neuroimage Clin. 2014 Aug 23;6:93-9. doi: 10.1016/j.nicl.2014.08.018. eCollection 2014.

5.

The roles of mitoferrin-2 in the process of arsenic trioxide-induced cell damage in human gliomas.

Wang C, Chen X, Zou H, Chen X, Liu Y, Zhao S.

Eur J Med Res. 2014 Sep 26;19:49. doi: 10.1186/s40001-014-0049-5.

6.

Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster delivery.

Maio N, Rouault TA.

Biochim Biophys Acta. 2015 Jun;1853(6):1493-512. doi: 10.1016/j.bbamcr.2014.09.009. Epub 2014 Sep 19. Review.

7.

mRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overload.

Brewer CJ, Wood RI, Wood JC.

Exp Hematol. 2014 Dec;42(12):1059-67. doi: 10.1016/j.exphem.2014.09.002. Epub 2014 Sep 16.

8.

Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation.

Martelli A, Puccio H.

Front Pharmacol. 2014 Jun 3;5:130. doi: 10.3389/fphar.2014.00130. eCollection 2014. Review.

9.

The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.

Urrutia PJ, Mena NP, Núñez MT.

Front Pharmacol. 2014 Mar 10;5:38. doi: 10.3389/fphar.2014.00038. eCollection 2014. Review.

10.

Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease.

Isaya G.

Front Pharmacol. 2014 Mar 3;5:29. doi: 10.3389/fphar.2014.00029. eCollection 2014. Review.

11.

Iron homeostasis in peripheral nervous system, still a black box?

Levi S, Taveggia C.

Antioxid Redox Signal. 2014 Aug 1;21(4):634-48. doi: 10.1089/ars.2013.5813. Epub 2014 Mar 13. Review.

12.

Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Grubman A, White AR, Liddell JR.

Br J Pharmacol. 2014 Apr;171(8):2159-73. doi: 10.1111/bph.12513. Review.

13.

Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.

Anzovino A, Lane DJ, Huang ML, Richardson DR.

Br J Pharmacol. 2014 Apr;171(8):2174-90. doi: 10.1111/bph.12470. Review.

14.

Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Singh N, Haldar S, Tripathi AK, Horback K, Wong J, Sharma D, Beserra A, Suda S, Anbalagan C, Dev S, Mukhopadhyay CK, Singh A.

Antioxid Redox Signal. 2014 Mar 10;20(8):1324-63. doi: 10.1089/ars.2012.4931. Epub 2013 Aug 15. Review.

15.

Iron and copper in mitochondrial diseases.

Xu W, Barrientos T, Andrews NC.

Cell Metab. 2013 Mar 5;17(3):319-28. doi: 10.1016/j.cmet.2013.02.004.

16.

Friedreich ataxia: neuropathology revised.

Koeppen AH, Mazurkiewicz JE.

J Neuropathol Exp Neurol. 2013 Feb;72(2):78-90. doi: 10.1097/NEN.0b013e31827e5762. Review.

17.

Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans.

Schiavi A, Torgovnick A, Kell A, Megalou E, Castelein N, Guccini I, Marzocchella L, Gelino S, Hansen M, Malisan F, Condò I, Bei R, Rea SL, Braeckman BP, Tavernarakis N, Testi R, Ventura N.

Exp Gerontol. 2013 Feb;48(2):191-201. doi: 10.1016/j.exger.2012.12.002. Epub 2012 Dec 13. Erratum in: Exp Gerontol. 2013 Sep;48(9):1001.

18.

Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia.

Whitnall M, Suryo Rahmanto Y, Huang ML, Saletta F, Lok HC, Gutiérrez L, Lázaro FJ, Fleming AJ, St Pierre TG, Mikhael MR, Ponka P, Richardson DR.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20590-5. doi: 10.1073/pnas.1215349109. Epub 2012 Nov 20.

19.

Cells lacking pfh1, a fission yeast homolog of mammalian frataxin protein, display constitutive activation of the iron starvation response.

Gabrielli N, Ayté J, Hidalgo E.

J Biol Chem. 2012 Dec 14;287(51):43042-51. doi: 10.1074/jbc.M112.421735. Epub 2012 Oct 31.

20.

Relation of cytosolic iron excess to cardiomyopathy of Friedreich's ataxia.

Ramirez RL, Qian J, Santambrogio P, Levi S, Koeppen AH.

Am J Cardiol. 2012 Dec 15;110(12):1820-7. doi: 10.1016/j.amjcard.2012.08.018. Epub 2012 Sep 21.

Items per page

Supplemental Content

Write to the Help Desk